MITF and cancer: Reflecting their cancer specific relevance, expression of MITF, PAX3, and BRN2 is significantly enriched in melanoma cell lines as seen in a panel covering >20 general cancer types (Barretina et al., 2012; Garnett et al., 2012; Wagner et al., 2007) (Figure 1a).